THERACLION: Theraclion Results Show Strong Recovery, Allowing Ambitious Plans finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Lymphoma Research Foundation Announces Sonali M Smith, MD as Scientific Advisory Board Chair prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE, PEA-PME eligible), an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU), announces
University of Virginia reveals new prostate cancer study
University of Virginia reveals new prostate cancer study By Dominga Murray | May 18, 2021 at 8:20 PM EDT - Updated May 18 at 8:20 PM
CHARLOTTESVILLE, Va. (WVIR) - Researchers at the University of Virginia Cancer Center just released a discovery that could boost treatment efforts for prostate cancer.
The findings focus on how hormones called androgens act on our cells. It sheds light on how these hormones interact inside the cell affecting gene activity.
The cells communicate through something called signal transduction pathways and understanding this better can lead to more effective treatments.
“This can help us understand why certain prostate cancer therapies fail. It can also reveal new drug targets in prostate cancer,” Bryce M. Paschal of the UVA School of Medicine’s department of biochemistry and molecular genetics said.